Lars Jørgen Østergaard

Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Maria Bolther, Institut for Klinisk Medicin - Infektionssygdomme
  • ,
  • Karen Lise Dahl Andersen
  • ,
  • Martin Tolstrup
  • Kumar Visvanathan, b Department of Emergency Medicine and Infection control , St. Vincent's Hospital and The University of Melbourne , Melbourne , Victoria , Australia.
  • ,
  • Ian Woolley, c Monash Infectious Diseases, Monash University , Melbourne , Victoria , Australia.
  • ,
  • Narelle Skinner, d Immunology Research Centre Department of Clinical Immunology , St. Vincent's hospital , Melbourne , Victoria , Australia.
  • ,
  • Rosemary Millen, d Immunology Research Centre Department of Clinical Immunology , St. Vincent's hospital , Melbourne , Victoria , Australia.
  • ,
  • Nadia Warner, e The Peter Doherty Institute for Infection and Immunity , Melbourne , Victoria , Denmark.
  • ,
  • Lars Østergaard
  • Søren Jensen-Fangel

This study investigated the immunomodulatory influence of IL10 producing B regulatory cells, Bregs (CD19+CD24hiCD38hi) to standard Twinrix® vaccination. We also investigated HBsAg specific T-cell mediated IFN-γ responses to Twinrix® which in theory could provide effective immunity despite low anti-HBs titer. A total of 309 hepatitis B negative health care students and workers completed a standard Twinrix® vaccination schedule (0, 1 and 6 months). Depending on the vaccination response the participants were divided in to non-, low- and high responders according to anti-HBs titer (<10, <100 and >1000 mIU/mL respectively) two months after completed vaccination schedule. Blood samples from baseline and after vaccination from all non- and low-responders (23 participants) and the same number of high-responders were used for flow cytometric analyses of IL10 producing Bregs and T-cell mediated IFN-γ responses. A decrease in levels of IL10 producing Bregs was observed after vaccination in high responders compared to non- and low-responders. Compiling non-and low-responders against high-responders showed a lower T-cell mediated IFN-γ response at baseline in non-and low-responders when stimulated with Engerix® vaccine. In contrary no positive correlation between IL10 producing Bregs or IFN-γ positive T-cells and anti-HBs titer was observed. Hence this study cannot prove that levels of IL10 producing Bregs or IFN-γ positive T cell affect HBV vaccine response.

Original languageEnglish
JournalHuman Vaccines & Immunotherapeutics
Pages (from-to)1483-1488
Number of pages6
Publication statusPublished - 3 Jun 2018

See relations at Aarhus University Citationformats

ID: 130996082